Macrophage Infiltration and ITGB2 Expression in ESCC : A Novel Correlation
Cancer Medicine · 2025
DOI: 10.1002/cam4.70604 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Tao Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Macrophages, Tumor-Associated Macrophages. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangxi Key Clinical Specialty Construction Project.
Abstract (Originalsprache)
Background
Esophageal squamous cell carcinoma (ESCC) is one of the most prevalent and lethal malignancies worldwide. Despite progress in immunotherapy for cancer treatment, its application and efficacy in ESCC remain limited. Therefore, there is an ongoing need to explore potential molecules and therapeutic strategies related to tumor immunity in ESCC.
Methods
In this study, we integrated high‐throughput sequencing data, gene chip data, single‐cell sequencing data, and various bioinformatics analysis methods along with experimental approaches to identify key genes involved in immune infiltration in ESCC and investigate their relationship with immune cell development, as well as the potential of these key genes in immunotherapy.
Results
We discovered and validated a positive correlation between macrophage infiltration and ITGB2 expression in ESCC. ITGB2 is overexpressed in ESCC and has potential as a prognostic biomarker for the disease. We present for the first time the finding that the expression of ITGB2 in infiltrating macrophages increases as these macrophages polarize toward a tumor‐promoting phenotype in ESCC. Moreover, during the progression of ESCC, ITGB2 expression in infiltrating macrophages is upregulated. The higher the expression of ITGB2, the more feasible it is to target macrophages. Additionally, we found that evaluating immune therapy responses in ESCC patients through ITGB2 expression is a viable approach. Furthermore, we identified three miRNAs associated with abnormal ITGB2 expression, providing insights into the upstream molecular interactions of ITGB2.
Conclusions
Macrophage infiltration in ESCC is closely associated with ITGB2, which holds significant potential for immunotherapy applications in ESCC. Based on our findings and prior studies, we propose a novel hypothesis: inducing M1 macrophages in vitro, knocking out ITGB2, and then reinfusing these ITGB2‐knockout M1 macrophages into ESCC patients may represent a promising new immunotherapy strategy, providing a new avenue for ESCC immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
ORCID-Profile: Huafu Zhou
Förderung
- Guangxi Key Clinical Specialty Construction Project
Zitieren
APA
Huang, T., Wei, L., Zhou, H., & Liu, J. (2025). Macrophage Infiltration and ITGB2 Expression in ESCC : A Novel Correlation. Cancer Medicine. https://doi.org/10.1002/cam4.70604
Vancouver
Huang T, Wei L, Zhou H, Liu J. Macrophage Infiltration and ITGB2 Expression in ESCC : A Novel Correlation. Cancer Medicine. 2025. doi:10.1002/cam4.70604
BibTeX
@article{Huang2025,
author = {Huang, Tao and Wei, Longqian and Zhou, Huafu and Liu, Jun},
title = {Macrophage Infiltration and ITGB2 Expression in ESCC : A Novel Correlation},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70604}
}
EUVIMED